Sagang, Baby Boy .

HRN: 24-25-70  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
OXACILLIN 500MG (VIAL)
07/26/2025
08/01/2025
IV
360mg
Q6h
Cellulitis
Checking Initial Appropriateness 
07/26/2025
MUPIROCIN 2%, 15G (TUBE)
07/26/2025
08/01/2025
TOPICAL
Thin Layer
TID
Cellulitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: